Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 15, Issue -, Pages 2653-2665
Publisher
Informa UK Limited
Online
2021-06-21
DOI
10.2147/dddt.s295223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases
- (2021) Chen-rei Wan et al. Pharmaceutics
- Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3, Randomized Trial
- (2020) Steven Yeh et al. OPHTHALMOLOGY
- Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab
- (2020) Caroline R. Baumal et al. OPHTHALMOLOGY
- Abicipar pegol for neovascular age-related macular degeneration
- (2020) Rehan M. Hussain et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2020) Arshad M. Khanani et al. JAMA Ophthalmology
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Innovative therapies for neovascular age-related macular degeneration
- (2019) Hasenin Al-Khersan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease
- (2019) Rehan M. Hussain et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti–VEGF Drug Type for 1 Year in the IRIS Registry
- (2018) Prethy Rao et al. OPHTHALMOLOGY
- Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
- (2018) Rufino Silva et al. OPHTHALMOLOGY
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2018) Daniel Barthelmes et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX study
- (2018) Kun Liu et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial
- (2018) Antonia M. Joussen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Gene therapy for age-related macular degeneration
- (2017) Nicholas A. Moore et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration
- (2017) Rehan M Hussain et al. EXPERT OPINION ON EMERGING DRUGS
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency
- (2017) Rehan M. Hussain et al. Ophthalmic Surgery Lasers & Imaging Retina
- An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications
- (2017) Evan N. Dunn et al. Ophthalmic Surgery Lasers & Imaging Retina
- First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
- (2016) James S. Talks et al. OPHTHALMOLOGY
- METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2016) Leah N. Kim et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
- (2016) J. Fernando Arevalo et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model
- (2015) Debanjan Bhattacharya et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
- (2015) Karl G. Csaky et al. OPHTHALMOLOGY
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol
- (2015) Karina Berg et al. OPHTHALMOLOGY
- CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE
- (2015) Eric H. Souied et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration
- (2014) Freekje van Asten et al. ACTA OPHTHALMOLOGICA
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Emerging treatments for wet age-related macular degeneration
- (2014) Adiel G Smith et al. EXPERT OPINION ON EMERGING DRUGS
- The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
- (2014) OPHTHALMOLOGY
- The Neovascular Age-Related Macular Degeneration Database
- (2014) Javier Zarranz-Ventura et al. OPHTHALMOLOGY
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration
- (2013) Annette Rasmussen et al. OPHTHALMOLOGY
- Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
- (2013) Ebenezer Daniel et al. OPHTHALMOLOGY
- Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment
- (2012) Mads Krüger Falk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
- (2012) A H Ross et al. EYE
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE
- (2012) Salomon Y. Cohen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study
- (2011) Lars Hjelmqvist et al. Journal of Ophthalmology
- Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface
- (2009) Tania M. Hansen et al. CELLULAR SIGNALLING
- Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
- (2009) Hajir Dadgostar et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started